Literature DB >> 30318957

High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats.

Fatemeh Kalaki-Jouybari1, Mehrnoosh Shanaki1, Maryam Delfan2, Sattar Gorgani-Firouzjae3, Soheyla Khakdan1.   

Abstract

Background: Exercise intervention is strongly recommended to manage metabolic diseases. In this study, we investigate, whether HIIT and CET can induce hepatic miR-122 expression, NAFLD rats with diabetes.
Methods: 40 Wistar rats divided into 2 groups, non-diabetic (NDC) and diabetic .Type 2 diabetes was induced by high-fat high-fructose diet (HFHFD). Then diabetic rats were subdivided into three groups: diabetic control (HFHFD + DC), CET (HFHFD + CET), and HIIT (HFHFD + HIIT). After eight weeks of exercise on a rodent treadmill, we measured miR-122 and its target genes expression in the liver of rats.
Results: HIIT decreased the expression of FAS, ACC, SREBP-1c compared with HFHFD + DC (p = .004, p = .032, p = .043, respectively), and could partially increase miR-122 expression as compared with HFHFD + DC (26.8%, p = .68).Conclusions: Exercise training could be a non-pharmacological intervention for improvement of NAFLD of diabetic rats by induction of miR-122. HIIT had a greater effect on NAFLD amelioration than CET.

Entities:  

Keywords:  Nonalcoholic fatty liver disease; continuous endurance training; high intensity interval training; mir-122; type 2 diabetes

Year:  2018        PMID: 30318957     DOI: 10.1080/13813455.2018.1510968

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  7 in total

1.  Exercise Training and Probiotic Lacticaseibacillus rhamnosus GG Reduce Tetracycline-Induced Liver Oxidative Stress and Inflammation in Rats with Hepatic Steatosis.

Authors:  Fariba Aghaei; Ehsan Arabzadeh; Hamideh Mahmoodzadeh Hosseini; Hossein Shirvani
Journal:  Probiotics Antimicrob Proteins       Date:  2022-09-28       Impact factor: 5.265

2.  Circulating Levels of microRNA-122 and Hepatic Fat Change in Response to Weight-Loss Interventions: CENTRAL Trial.

Authors:  Mengying Wang; Qiaochu Xue; Xiang Li; Knut Krohn; Stefanie Ziesche; Uta Ceglarek; Matthias Blüher; Maria Keller; Anat Yaskolka Meir; Yoriko Heianza; Peter Kovacs; Iris Shai; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

3.  High intensity interval training improves diabetic cardiomyopathy via miR-1 dependent suppression of cardiomyocyte apoptosis in diabetic rats.

Authors:  Maryam Delfan; Mahmoud Delphan; Mohammd Reza Kordi; Ali Asghar Ravasi; Majid Safa; Sattar Gorgani-Firuzjaee; Ahmad Fatemi; Fatemeh Bandarian; Ensieh Nasli-Esfahani
Journal:  J Diabetes Metab Disord       Date:  2020-01-28

4.  Ameliorative effects of high intensity interval training and Lactobacillus rhamnosus GG Protect against tetracycline-induced fatty liver in rats: a gene expression profiling comparative study.

Authors:  Hamideh Mahmoodzadeh Hosseini; Hossein Shirvani; Fariba Aghaei; Ehsan Arabzadeh; Martin Hofmeister
Journal:  EXCLI J       Date:  2022-07-21       Impact factor: 4.022

5.  Effects of two workload-matched high intensity interval training protocols on regulatory factors associated with mitochondrial biogenesis in the soleus muscle of diabetic rats.

Authors:  Maryam Delfan; Alieh Vahed; David J Bishop; Raheleh Amadeh Juybari; Ismail Laher; Ayoub Saeidi; Urs Granacher; Hassane Zouhal
Journal:  Front Physiol       Date:  2022-09-23       Impact factor: 4.755

6.  Perspectives on Interval Exercise Interventions for Non-Alcoholic Fatty Liver Disease.

Authors:  Hidetaka Hamasaki
Journal:  Medicines (Basel)       Date:  2019-08-01

7.  High-Intensity Interval Training Reversed High-Fat Diet-Induced M1-Macrophage Polarization in Rat Adipose Tissue via Inhibition of NOTCH Signaling.

Authors:  Mehrnoosh Shanaki; Maryam Khosravi; Arezoo Khoshdooni-Farahani; Alireza Dadashi; Mohammad Foad Heydari; Maryam Delfan; Hanieh Jafary; Sattar Gorgani-Firuzjaee
Journal:  J Inflamm Res       Date:  2020-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.